TCMBANKIN000064 |
diosgenin |
AKOS025402315; MolPort-028-744-580; (25R)-5-Spirosten-3beta-ol; 3beta-Hydroxy-5-spirostene; nitogenin; NSC 226132; Spirost-5-en-3-ol, (3beta,25S)-; diosgenin ; AC-8024; 512-04-9; 22-epi-Yamogenin; C08898; D1634_SIGMA |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN002780 |
arachide acid |
|
|
|
|
TCMBANKIN004987 |
5, 5″, 7, 7″, 4′, 4′′′-hexahydroxy-(2′, 6″)-biflavone |
|
|
|
|
TCMBANKIN005271 |
anemonin |
1,2-Cyclobutanediacrylic acid, 1,2-dihydroxy-, di-gamma-lactone; CHEBI:80791; 508-44-1; UNII-G99XG5B674 component JLUQTCXCAFSSLD-NXEZZACHSA-N; AJ-28210; (5S,6S)-1,7-Dioxadispiro[4.0.4.2]dodeca-3,9-diene-2,8-dione; Anemonine; 5-19-05-00101 (Beilstein Handbook Reference); Pulsatilla camphor; 1,7-Dioxadispiro(4.0.4.2)dodeca-3,9-diene-2,8-dione, trans-; BRN 0009390; Anemonin; C16913; ZINC1609644; MolPort-020-006-010; Anemone camphor |
C10H8O4 |
192.17 |
C1CC2(C13C=CC(=O)O3)C=CC(=O)O2 |
TCMBANKIN016874 |
lapphol e |
|
|
|
|
TCMBANKIN017363 |
raddeanoside R8 |
|
C65H106O30 |
1367.52 |
CC(=O)OCC1C(C(C(O1)N2C(=CC(=N2)CI)C(=O)N)OC(=O)C)OC(=O)C |
TCMBANKIN022916 |
arctinin |
|
|
|
|
TCMBANKIN023472 |
neoarctin b |
C17683; neoarctin B; CHEBI:81272 |
C42H46O12 |
742.8 g/mol |
COC1=CC(=CC(=C1O)OC)CC2C(COC2=O)CC3=CC(=C(C=C3)C4=C(C=C(C=C4)CC5COC(=O)C5CC6=CC(=C(C(=C6)OC)O)OC)OC)OC |
TCMBANKIN024305 |
(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
(4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-[[(2S,3R,4S,5S)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-10-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
C47H76O16 |
897.1 |
|
TCMBANKIN024628 |
isoarctigenin |
|
C21H24O6 |
372.4 g/mol |
COC1=C(C=C(C=C1)CC2C(COC2=O)CC3=CC(=C(C=C3)O)OC)OC |
TCMBANKIN025358 |
benzoic acid |
Benzoic acid, 2-[(carboxymethyl)amino]-4-chloro-; 2-[(carboxymethyl)amino]-4-chlorobenzoic acid; DTXSID70455462; BG00311790; AC-17987; AX8062950; 2-carboxymethylamino-4-chlorobenzoic acid; KB-223858; AK140629; 99282-79-8; benzoicacid; CTK5I0315; 2-(Carboxymethyl-amino)-4-chloro-; AKOS015963713; SCHEMBL3236365; 2-(carboxymethylamino)-4-chlorobenzoic acid; benzoic acid ; 2-(CARBOXYMETHYL-AMINO)-4-CHLORO-BENZOIC ACID; AJ-79604; 2-((Carboxymethyl)amino)-4-chlorobenzoic acid; UDXGKLGUAJLLCJ-UHFFFAOYSA-N; ZINC21988796 |
C7H6O2 |
122.12 |
C1=CC(=C(C=C1Cl)NCC(=O)O)C(=O)O |
TCMBANKIN026954 |
propyl cyclopentane |
Propylcyclopentane; 82180_FLUKA; ST5411564; WLN: L5TJ A3; Cyclopentane, propyl-; n-Propylcyclopentane; BRN 1900338; NSC 73947; EINECS 218-042-5; 4-05-00-00125 (Beilstein Handbook Reference); NSC73947; 1-Cyclopentylpropane; InChI=1/C8H16/c1-2-5-8-6-3-4-7-8/h8H,2-7H2,1H; 2040-96-2 |
C8H16 |
112.21 |
CCCC1CCCC1 |
TCMBANKIN027689 |
pharbitin |
|
|
|
|
TCMBANKIN030378 |
4-methylcyclohexanone |
AC1Q2QQC; I14-20909; NSC 3816; InChI=1/C7H12O/c1-6-2-4-7(8)5-3-6/h6H,2-5H2,1H; 0L1R78K79S; Z57073963; VGVHNLRUAMRIEW-UHFFFAOYSA-N; Methylcyclohexanone [UN2297] [Flammable liquid]; 4-methylcyclohexan-1-one; NSC-3816; 4-07-00-00044 (Beilstein Handbook Reference); ACN-036217; KSC271E7B; 4-methyl cyclohexanone; Methyl-4 cyclohexanone-1; F0001-1540; AI3-15916; TR-020466; CYCLOHEXANONE,4-METHYL; RTR-020466; BB_SC-6867; 4-Methylcyclohexanone, >=99%; BBL013180; KB-72735; LS-57333; 4-methyl-cyclohexan-1-one; AC1L1XJS; methycyclohexanone; PS-5543; AN-21521; EINECS 209-665-3; MolPort-001-769-168; BRN 0506746; 589-92-4; M0199; CJ-10929; UNII-0L1R78K79S; AKOS000118729; p-Methyl cyclohexanone; 4-Methyl-1-cyclohexanone; 4-METHYLCYCLOHEXANONE; A832099; ZINC3861284; 4-methylcyclohexane-1-one; AB1009831; SC-27685; BC219613; 4-Methyl-1-oxocyclohexane; AJ-46159; SCHEMBL104009; CTK1H1270; NSC3816; methyl-cyclohexanone; 4-METHYL-CYCLOHEXANONE; MCULE-5534475096; UN2297; KS-00000V7H; Metylocykloheksanon [Polish]; ACN-S002653; I14-9086; FEMA 3948; Metylocykloheksanon; J-515780; FT-0619075; RP19070; ST24023614; 4-Methylcyclohexanone, 99%; ACMC-1AVXU; AK114311; 5-METHYL-2-OXOCYCLOHEXYL; LS-57336; MFCD00001643; 4methylcyclohexanone; STL163959; Tetrahydro-p-cresol; Methylcyclohexanone [UN2297] [Flammable liquid]; TRA-0205797; 4-Methylcyclohexanone, 98% 25g; EINECS 215-556-1; Cyclohexanone, 4-methyl-; 40471-53-2; DTXSID5060435; Methyl-4 cyclohexanone-1 [French]; ANW-33108 |
C7H12O |
112.17 g/mol |
CC1CCC(=O)CC1 |
TCMBANKIN030975 |
lignan |
ethyl 6,7-dimethoxy-3-methyl-4-oxo-1-(3,4,5-trimethoxyphenyl; AC1L64PD; NSC93090; J3.625.444K; AKOS030600072; SCHEMBL30935; DTXSID90293944; CTK5C2772; AK642709; Lignan; 6549-68-4; ethyl 6,7-dimethoxy-3-methyl-4-oxo-1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate; ethyl 6,7-dimethoxy-3-methyl-4-oxo-1-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1H-naphthalene-2-carboxylate; NSC-93090; AC1Q6N8A |
C25H30O8 |
458.5 g/mol |
CCOC(=O)C1C(C(=O)C2=CC(=C(C=C2C1C3=CC(=C(C(=C3)OC)OC)OC)OC)OC)C |
TCMBANKIN034214 |
ranunculin |
644-69-9; (5S)-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-5H-furan-2-one; C08512; (5S)-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]-5H-furan-2-one; (5S)-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]-5H-furan-2-one; (5S)-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-5H-furan-2-one; Ranunculin |
C11H16O8 |
276.24 g/mol |
C1=CC(=O)OC1COC2C(C(C(C(O2)CO)O)O)O |
TCMBANKIN035439 |
guanfu base A |
guan fu base a |
C24H31NO6 |
429.51 |
CC(=O)OC1CC2(CN3C4C2C5(C1)C3C6(C(C7C(C5C6(C4)CC7=C)O)OC(=O)C)O)C |
TCMBANKIN036613 |
lappaol e, c, f |
|
|
|
|
TCMBANKIN036794 |
raddeanin A |
raddeanin a |
C47H76O16 |
897.1 |
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(C(COC3OC4CCC5(C(C4(C)C)CCC6(C5CC=C7C6(CCC8(C7CC(CC8)(C)C)C(=O)O)C)C)C)O)O)CO)O)O)O)O)O |
TCMBANKIN038150 |
Lappaol C |
64855-00-1; 4-[[3-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-y; 2(3H)-Furanone, dihydro-4-((4-hydroxy-3-(2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl)ethyl)-5-methoxyphenyl)methyl)-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R,4R)-; 9R9RZN471Y; CHEBI:81275; C17686; lappaol c; UNII-9R9RZN471Y; LAPPAOL C |
|
555 |
|
TCMBANKIN038754 |
Arctiin |
4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-oxolanone; 2-(hydroxymethyl)-6-methyloxane-3,4,5-triol; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]methyl]tetrahydrofuran-2-one; AIDS-002468; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]methyl]-2-tetrahydrofuranone; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]methyl]oxolan-2-one; 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)-3-((4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl)methyl)dihydro-, (3R-trans)- (9CI); Arctiin (8CI); 2(3H)-Furanone, 4-[(3,4-dimethoxyphenyl)methyl]-3-[[4-(b-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-, (3R,4R)-; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]oxolan-2-one; AIDS002468; (3R,4R)-4-(3,4-dimethoxybenzyl)-3-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-benzyl]tetrahydrofuran-2-one; NSC 315527; ACon1_001261; 4-[(3,4-dimethoxyphenyl)methyl]-3-[(3-methoxy-4-oxidanyl-phenyl)methyl]oxolan-2-one; 2-(hydroxymethyl)-6-methyl-oxane-3,4,5-triol; MEGxp0_000527; A814488 |
C27H34O11 |
535 |
c1(OC([H])([H])[H])c([H])c(C([H])([H])[C@@]2([H])C(=O)OC([H])([H])[C@]2([H])C([H])([H])c3c([H])c(OC([H])([H])[H])c(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])
c([H])c3[H])c([H])c([H])c1OC([H])([H])[H] |
TCMBANKIN039097 |
Lappaol A |
LAPPAOL A; CHEBI:81273; UNII-YU544603T7; 62333-08-8; lappaol a; YU544603T7; C17684 |
|
536.57 |
|
TCMBANKIN040539 |
lappaol D |
C17812; CHEBI:81350; lappaol d |
C31H36O10 |
569 |
c1([C@@]([H])(C([H])([H])O[H])[C@]([H])(c2c([H])c(OC([H])([H])[H])c(O[H])c([H])c2[H])O[H])c([H])c(C([H])([H])[C@]3(C(=O)OC([H])([H])[C@]3([H])C([H])([H])c4c([H])c([H])c(OC([H])([H])[H])c(OC([H])([H])[
H])c4[H])[H])c([H])c(OC([H])([H])[H])c1O[H] |
TCMBANKIN040878 |
Lappaol F |
lappaol f |
|
714.75 |
|
TCMBANKIN041194 |
Lappaol E |
lappaol e |
C30H34O10 |
554.59 |
COC1=C(C=CC(=C1)CC2C(COC2=O)CC3=CC(=C(C=C3)OC(CO)C(C4=CC(=C(C=C4)O)OC)O)OC)O |
TCMBANKIN041845 |
Lappaol H |
lappaol h |
|
750.78 |
|
TCMBANKIN043906 |
Lappaol B |
2(3H)-Furanone, 3-(((2S,3R)-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-5-benzofuranyl)methyl)-4-((3,4-dimethoxyphenyl)methyl)dihydro-, (3R,4R)-; 62359-60-8; CHEBI:81274; 4-[(3,4-dimethoxyphenyl)methyl]-3-[[2-(4-hydroxy-3-methoxyph; lappaol b; E9QPE836PM; LAPPAOL B; UNII-E9QPE836PM; C17685 |
|
550.6 g/mol |
|
TCMBANKIN046864 |
Raddeanin E |
raddeanin e; raddeanine |
|
394.46 |
|
TCMBANKIN047294 |
raddeanin C |
raddeanin c |
C24H34O7 |
434.52 |
|
TCMBANKIN048200 |
hypaconitine |
Hypaconitine; aconitine alkaloids |
C33H45NO10 |
616 |
C1([H])([H])[C@]([H])(OC([H])([H])[H])[C@]2([C@@]([H])([C@@]([H])([C@]3(OC(C([H])([H])[H])=O)[C@@]([H])([C@@]([H])(OC(=O)c4c([H])c([H])c([H])c([H])c4[H])[C@]([C@]([H])(OC([H])([H])[H])[C@]3([H])O[H])(
O[H])C5([H])[H])[C@]25[H])[C@]6([H])OC([H])([H])[H])N(C([H])([H])[H])C7([H])[H])[C@@]6([H])[C@@]7(C([H])([H])OC([H])([H])[H])C1([H])[H] |
TCMBANKIN049334 |
Isoastilbin |
4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R,3R)-; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chroman-4-one; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one; 29838-67-3; (2R,3R)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; BG01741591; dihydroquercetin-3-O-alpha-LRhap; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one; NCGC00168909-01; Dihydroquercetin 3-O-.alpha.-L-rhamnopyranoside; (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside; 4H-1-Benzopyran-4-one, 3-[(6-deoxy-.alpha.-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R,3R)-; NCGC00168909-02!(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one; AKOS025402308; ZINC31156118; (2R-trans)-3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4- dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; Dihydroquercitrin; MEGxp0_000363; AN-8429; W1551; ACon1_000616; 4H-1-Benzopyran-4-one,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-,(2R,3R)-; A-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4h-1-benzopyran-4-one; MolPort-001-740-537; NP-000928; 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2R-trans)-; Taxifolin 3-O-rhamnoside; AK175743; (2r-trans)-3-((6-deoxy-; C17449; AC-8008; (2R-trans)-3-((6-Deoxy-alpha-L-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; 54141-72-9; Isoastilbin; BG01156477; AC1Q6NL7; CHEMBL486017; ZROGCCBNZBKLEL-MPRHSVQHSA-N; CHEBI:38200; MCULE-6234117773; Neoisoastilbin; Astilbin; Q-100379; AC1L3OHH |
C21H22O11 |
450.393 |
c1(O[H])c([H])c(O[C@]([H])(c2c([H])c(O[H])c([H])c(O[H])c2[H])[C@@](O[C@@]([H])(O[C@@]3([H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])([H])C4=O)c4c(O[H])c1[H] |
TCMBANKIN057937 |
galactitol |
meso-galactitol;18089-21-9; EINECS 210-165-2; CHEBI:16813; D0256_SIGMA; NSC 1944; ZINC04521466; (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol; 40742-76-5; ZINC02034453; AI3-19423;C01507; C-25615; Sorbo; I0725; I14-60913; KB-53227; CTK8B4049; L-Iditol, >=98%; FBPFZTCFMRRESA-UNTFVMJOSA-N; AC1NUSPZ; DB-051581; 488-45-9; ANW-43765; CHEBI:18202; MolPort-003-848-134; L-Iditol; CC-29952; AKOS024258141; FT-0627851; K-9194; KS-00000XZK; WURCS=1.0/1,0/[h2121h]; SCHEMBL435775; ZINC5178945; W-202860; (2S,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; L-Idit; MFCD00064289;dulcitol |
C6H14O6 |
182.17 g/mol |
C(C(C(C(C(CO)O)O)O)O)O |
TCMBANKIN058314 |
benzaldehyde |
SCHEMBL896024; A804633;Benzoic aldehyde;WLN: VHR;InChI=1/C7H6O/c8-6-7-4-2-1-3-5-7/h1-6; CHEBI:17169; Benzene methylal; B1334_ALDRICH; Ald3-H_000012; Benzenecarbonal; Benzaldehyde (natural); NCGC00091819-01; AI3-09931; EINECS 202-860-4; Oil of Bitter Almond; ST5213372; Artificial essential oil of almond; nchembio814-comp15; LS-27; EPA Pesticide Chemical Code 008601; BENZALDEHYDE; W212709_ALDRICH; Ald3.1-H_000160; D02314; Benzenemethylal; NCI-C56133; HSDB 388; 12010_FLUKA; Ald3.1-H_000479; Benzaldehyde FFC; W212717_ALDRICH; Benzene carbaldehyde; CCRIS 2376; 100-52-7; Benzaldehyde [UN1990] [Class 9]; Caswell No. 076; Benzenecarboxaldehyde; Benzoyl hydride; Ald3.1-H_000798; Benzaldehyde (NF); Artificial Almond Oil; Benzaldehyde [USAN]; Artificial Bitter Almond Oil; 09143_FLUKA; C00261; Synthetic oil of bitter almond; FEMA No. 2127; ghl.PD_Mitscher_leg0.170; c0279; 418099_ALDRICH; Benzoic aldehyde; Benzene carboxaldehyde; benzanoaldehyde; Bitter almond oil, synthetic; UN1990; NSC7917; Almond Artificial Essential Oil; NSC 7917; Benzadehyde; Phenylmethanal |
C7H6O |
106.12 |
C1=CC=C(C=C1)C=O |
TCMBANKIN059521 |
B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(=C)C1C2)C |
TCMBANKIN060600 |
2-methyl cyclopentanol |
|
C6H12O |
100.16 |
CC1CCCC1O |
TCMBANKIN060800 |
propyl cyclopentane |
|
C8H16 |
112.21 |
CCCC1CCCC1 |
TCMBANKIN060879 |
Linolic acid |
|
C18H32O2 |
280.4 g/mol |
CCCCCC=CCC=CCCCCCCCC(=O)O |
TCMBANKIN061511 |
arctigenin |
AIDS002466; C10545; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one; arctigenin ; Arctigenin; 41328-87-4; MLS002473154; NCGC00025291-01; MEGxp0_001799; HMS2198I14; Arctigenin, (+)-; (3S,4S)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one; 695QU32V04; SMR001397246; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one; (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxy-3-methoxy-benzyl)tetrahydrofuran-2-one; 7770-78-7; 26687-78-5; (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone; AIDS-002466; ACon1_000416; Tocris-1777; (−)-Arctigenin; DTXSID50233381; UNII-2FD8L150E7 component NQWVSMVXKMHKTF-CVEARBPZSA-N; 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R-trans)-; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2-tetrahydrofuranone; (-)-Arctigenin; UNII-695QU32V04; 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3S-trans)-; A1854_SIGMA; Arctigenen; 84413-77-4; Arctigenin, trans-(+)-; (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxy-phenyl)methyl]oxolan-2-one; (+)-Arctigenin; 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3S,4S)-; ZINC899931; 2(3H)-Furanone, 4-((3,4-dimethoxyphenyl)methyl)dihydro-3-((4-hydroxy-3-methoxyphenyl)methyl)-, (3R,4R)-; CHEMBL369142; (-)-arctigenin |
C21H24O6 |
372.4 g/mol |
COC1=C(C=C(C=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)O)OC)OC |
TCMBANKIN061627 |
matairesinol |
41328-88-5; AIDS030806; (-)-Matairesinol; Matairesinol; 3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone; AIDS-030806; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxy-phenyl)methyl]tetrahydrofuran-2-one; ARTIGENIN CONGENER; (3R,4R)-3,4-bis(4-hydroxy-3-methoxy-benzyl)tetrahydrofuran-2-one; 580-72-3; DIBENZYLBUTYROLACTONE LIGNANOLIDE; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one; 40043_FLUKA; MEGxp0_001689; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxy-phenyl)methyl]oxolan-2-one; Arbo 5; C10682; (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2-tetrahydrofuranone; (alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone; ACon1_001075; 2(3H)-Furanone, dihydro-3,4-bis((4-hydroxy-3-methoxyphenyl)methyl)-, (3R-trans)-;(- )-matairesinol;MAX |
C20H22O6 |
358.4 g/mol |
COC1=C(C=CC(=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)O)OC)O |